ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 280

Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus

R. Paola Daly1, Nicole Wanty2, Maggie Maloney1, Stacey Boyd3, Karin Tse1 and Karen Goldstein4, 1Lupus Foundation of America, Washington, DC, 2KDH Research & Communication, Atlanta, GA, 3American College of Rheumatology, Atlanta, GA, 4Ogilvy, Washington, DC

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Communication, Education, patient and health literacy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Healthcare Disparities in Rheumatology Poster – ARHP

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Lupus is a complex, chronic autoimmune disease that has significantly higher prevalence and incidence among minority women.[i] In an effort to reduce the time to diagnosis for populations with highest risk, ACR and the Lupus Foundation of America created a digital awareness and education campaign, Be Fierce. Take Control., intended for African American and Latino women ages 18-25 who may be experiencing lupus symptoms to raise their awareness of lupus and provide evidence-based information on what to do next.

Methods:

Formative research was conducted via web-based focus groups with 60 individuals meeting intended audience criteria to gather information on help and information seeking behavior, attitudes towards health care, and appropriateness of culturally relevant language. Using this information, a digital campaign involving mobile ads, videos and articles all directing to a campaign website was developed and tested for cultural relevancy, health literacy, scientific accuracy, and general appeal. Testing was completed using user panels, as well as a rigorous review and approval process by two lupus clinician/researchers. Campaign assets were finalized using feedback, and the campaign was launched in June 2017. Following the first year of launch, user testing was conducted with 10 individuals in the intended audience to provide detailed information on how users navigated the campaign website in order to improve user experience.

Results:

The website received a total 114,866 page views in the first year. The majority of visitors read the home page, followed by a page providing reliable resources of next steps to take if lupus symptoms are suspected. 72% of visitors who responded to a helpfulness poll present on each page indicated that the web-content was helpful. User testing post-launch revealed 9 out of 10 users could describe lupus as an autoimmune disease after reviewing the site, and 7 out of 10 users had a better understanding of lupus and would be comfortable enough to approach a doctor about potential lupus symptoms. New updates were released in May 2018 based on these results. In addition, a series of lupus articles were released through a paid media partnership with A Plus media, receiving 345,145 views in the first three months. The partnership also included development and promotion of a video featuring NY Sharks women’s football team, depicting the theme of being fierce in their lives with an underlying message on taking control of your health. The video gained attention from celebrity influencers, generating over 2 million views with nearly a third of its YouTube viewers watching the entire video.

Conclusion:

Be Fierce. Take Control. provides an example of a well-designed, culturally competent online resource to increase awareness and knowledge of lupus symptoms in African American and Latino women ages 18-25 who may be experiencing lupus symptoms. This is the first digital-only lupus campaign targeted to this audience, highlighting the importance of rigorous testing to ensure cultural relevance in health communication campaigns.

[i] Centers for Disease Control and Prevention. Lupus Detailed Fact Sheet. https://www.cdc.gov/lupus/facts/detailed.html. Published May 3, 2018. Accessed June 1, 2018.


Disclosure: R. P. Daly, Lupus Foundation of America, 3; N. Wanty, KDH Research and Communication, 3; M. Maloney, Lupus Foundation of America, 3,Centers for Disease Control and Prevention, 2; S. Boyd, American College of Rheumatology, 3,Centers for Disease Control and Prevention, 2; K. Tse, Lupus Foundation of America, 3; K. Goldstein, Ogilvy, 3.

To cite this abstract in AMA style:

Daly RP, Wanty N, Maloney M, Boyd S, Tse K, Goldstein K. Be Fierce. Take Control.TM an Evidence-Based Digital Lupus Awareness and Education Campaign for Young Minority Women at Risk for Lupus [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/be-fierce-take-control-tm-an-evidence-based-digital-lupus-awareness-and-education-campaign-for-young-minority-women-at-risk-for-lupus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/be-fierce-take-control-tm-an-evidence-based-digital-lupus-awareness-and-education-campaign-for-young-minority-women-at-risk-for-lupus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology